Concepedia

Hanne Due

HD

5

Publications

105

Citations

5

H-Index

2019

Active since

Affiliations

Aalborg University Hospital(Current)

Aalborg University

Aarhus University

Hanne Due is an author at Aalborg University Hospital specializing in tumor microenvironment, immunology, and oncology.

ORCID

Top concepts

Publications per year

2019–2022

5

Publications

5

MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma

Hanne Due, Anna A. Schönherz, Laura Barrett Ryø et al. · Blood Advances · 2019 · 30 citations · Full text

, , +16

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients

Maria Bach Laursen, Linn Reinholdt, Anna A. Schönherz et al. · Oncotarget · 2019 · 27 citations · Full text

Identification of BLNK and BTK as mediators of rituximab‐induced programmed cell death by CRISPR screens in GCB‐subtype diffuse large B‐cell lymphoma

Emil Aagaard Thomsen, Anne Bruun Rovsing, Mads Valdemar Anderson et al. · Molecular Oncology · 2020 · 20 citations · Full text

, , +17

Hsp90 inhibition sensitizes DLBCL cells to cisplatin

Linnéa Schmidt, Issa Ismail Issa, Hulda Haraldsdóttir et al. · Cancer Chemotherapy and Pharmacology · 2022 · 15 citations · Full text

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

Hanne Due, Rasmus Froberg Brøndum, Ken H. Young et al. · BMC Cancer · 2020 · 13 citations · Full text

Rows per page

1–5 of 5